Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydralazine-isosorbide-dinitrate in African Patients With Acute Heart Failure
NCT01822808Phase 3Unknown
- Sponsor
- University of Cape Town
- Start
- Jan 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute Heart Failure (AHF) and left ventricular dysfunction comparing Hydralazine + Isosorbide dinitrate (HYIS) with Placebo (2 arms). Primary endpoint: Time to death or Heart Failure re-admission at day 180. Status: unknown.
02
Drugs
hydralazineisosorbide dinitrate
03
Conditions
Acute Heart Failure (AHF)left ventricular dysfunction
Beyond the preview
Go deeper on NCT01822808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822808.